Hosted at the Yuma Civic Center, companies, growers, and researchers got together and discussed topics like smart farms, water conservation techniques, and ag-tech integration.

On Wednesday, Allogene Therapeutics Inc (ALLO) stock saw a decline, ending the day at $2.72 which represents a decrease of $-0.12 or -4.23% from the prior close of $2.84. The stock opened at $2.86 and ...

Piper Sandler analyst Biren Amin maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target ...

Piper Sandler analyst Biren Amin lowered the firm’s price target on Allogene Therapeutics (ALLO) to $9 from $11 and keeps an Overweight ...

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

Acorns’ spare-change savings tool and cash-back rewards program make investing easy. But the management fee on small accounts is steep. The investing information provided on this page is for ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Thank you for standing by. My name is Bella, and I will be your ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Representatives of the city of Joplin, the school district and t Area Chamber of Commerce gathered at a ceremony Tuesday to mark the start of Allo Fiber's construction of a fiber-optic network that ...

Allogene Therapeutics has dropped plans to target one of its allogeneic CAR-Ts at leukemia in the face of competition from ...

coming to an end Intern Signing Day celebrates new hires at Ozark Center Creative Learning Alliance receives $25K grant Allo ...